109 related articles for article (PubMed ID: 26298436)
1. Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.
Kulvik M; Kallio M; Laakso J; Vähätalo J; Hermans R; Järviluoma E; Paetau A; Rasilainen M; Ruokonen I; Seppälä M; Jääskeläinen J
Appl Radiat Isot; 2015 Dec; 106():207-12. PubMed ID: 26298436
[TBL] [Abstract][Full Text] [Related]
2. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
[TBL] [Abstract][Full Text] [Related]
3. Boron biodistribution in beagles after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose complex.
Kulvik ME; Vähätalo JK; Benczik J; Snellman M; Laakso J; Hermans R; Järviluoma E; Rasilainen M; Färkkilä M; Kallio ME
Appl Radiat Isot; 2004 Nov; 61(5):975-9. PubMed ID: 15308178
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
7. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
8. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
[TBL] [Abstract][Full Text] [Related]
9. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
10. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
Joel DD; Coderre JA; Micca PL; Nawrocky MM
J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
[TBL] [Abstract][Full Text] [Related]
11. L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours.
Watanabe T; Tanaka H; Fukutani S; Suzuki M; Hiraoka M; Ono K
Cancer Lett; 2016 Jan; 370(1):27-32. PubMed ID: 26455769
[TBL] [Abstract][Full Text] [Related]
12. Boron biodistribution study in colorectal liver metastases patients in Argentina.
Cardoso J; Nievas S; Pereira M; Schwint A; Trivillin V; Pozzi E; Heber E; Monti Hughes A; Sanchez P; Bumaschny E; Itoiz M; Liberman S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S76-9. PubMed ID: 19375931
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
[TBL] [Abstract][Full Text] [Related]
14. Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.
Farías RO; Garabalino MA; Ferraris S; Santa María J; Rovati O; Lange F; Trivillin VA; Monti Hughes A; Pozzi EC; Thorp SI; Curotto P; Miller ME; Santa Cruz GA; Bortolussi S; Altieri S; Portu AM; Saint Martin G; Schwint AE; González SJ
Med Phys; 2015 Jul; 42(7):4161-73. PubMed ID: 26133616
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
[TBL] [Abstract][Full Text] [Related]
17. Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f.
Sköld K; H-Stenstam B; Diaz AZ; Giusti V; Pellettieri L; Hopewell JW
Acta Neurol Scand; 2010 Jul; 122(1):58-62. PubMed ID: 19951268
[TBL] [Abstract][Full Text] [Related]
18. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
19. Assessment of
Shimosegawa E; Isohashi K; Naka S; Horitsugi G; Hatazawa J
Ann Nucl Med; 2016 Dec; 30(10):749-755. PubMed ID: 27586407
[TBL] [Abstract][Full Text] [Related]
20. From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy.
Barth RF
Appl Radiat Isot; 2015 Dec; 106():22-8. PubMed ID: 26149807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]